Table 7.
LH Prevalence in Patients of Different Age Grades
| Author (Year) | Age | LH Prevalence (%) | Overall | P-value | ||
|---|---|---|---|---|---|---|
| >18, ≤30 | 31–60 | >60 | ||||
| Lin et al (2021)19 | 40/23 (63.49%) | 43/14 (75.44%) | 69.17% | 120 | 0.1570 | |
| Arora et al (2021)20 | 54/58 (48.21%) | 192/120 (61.54%) | 44/32 (57.89%) | 58.00% | 500 | 0.0142 |
| Gentile et al (2021)21 | 62.0 ± 15.0 | 46.15% | 780 | |||
| Thewjitcharoen et al (2020)22 | 64.8 ± 14.2 | 37.25% | 400 | |||
| Gentile et al (2020)12 | 396/817 (32.65%) | 322/410 (43.99%) | 58.52% | 1227 | <0.0001 | |
| Lian et al (2018)23 | 48.0± 3.0 | 56.67% | 300 | |||
| Tsadik et al (2018)24 | 58.52% | 176 | ||||
| Hernar et al (2017)17 | 36.0 (18–82) | 51.63% | 215 | |||
| Al Hayek et al (2016)25 | 47.70% | 174 | ||||
| Sawatkar et al (2014)26 | 41.00% | 239 | ||||